Historical Newspapers of South Carolina

Below is the OCR text representation for this newspapers page. It is also available as plain text as well as XML.

Pope adds to list of possible successors BY NICOLE WINFIELD TUB ASSOCIATED PRESS VATICAN CITY - His health failing, Pope John Paul II added 30 names to the list of his possible successors Tuesday, installing a diverse collection of cardinals in a consistory some say may be his last. In a ritual-filled ceremony on the steps of St. Peter’s Basilica, the 83-year-old pope was giving the new "princes of the church” their red hats and declaring them members of the elite band of churchmen who will elect the next pope. "We don’t know whether that will be in one month or five years,” said Scottish Archbishop Keith O’Brien, one of the new car dinals. "But that’s really the pri ority for cardinals.” The pope’s increasing frailty, on display during a rigorous week of ceremonies surrounding his 25th anniversary, added poignan cy to Tuesday’s consistory. As a result, the current roster of cardinals is considered to be the list of possible popes, since cardi nals largely choose from among themselves for the top job in the Roman Catholic Church. John Paul himself didn’t read out the names of the new cardinals, leaving it to an aide. In the few prayers he did deliver, the pontiff slurred his words, symptoms of the Parkinson’s disease which has made it difficult for him to speak. Tuesday’s ceremony brought to 194 the active members of the College of Cardinals, although only 135 of them are under age 80 and thus eligible to vote in a con clave. Of those 135, John Paul has named all but five. Yet picking the next pope from among them is anyone’s guess, since the group is still large and geographically diverse. "It’s funny, nobody is whis pering ‘he’ll be the next man,”’ said Cardinal Lubomyr Husar of Ukraine. "Nobody has arisen as a personality.” In fact, the college has gotten so large that cardinals wore tags with their names and home dioce ses during meetings at the Vatican last week. Certainly, there are a handful of contenders, or "papabili,” in cluding one of the new cardinals: Italy’s Angelo Scalo. He’s the pa triarch of Venice—a position that produced three popes in the 20th century. The new candidates come from around the world, from Australia to Zagreb, Vietnam to Venice, and on the whole follow John Paul’s conservative bent. O’Brien, however, made waves a few weeks ago when he suggested that celibacy and con traception should be up for dis cussion. Current church teaching requires celibacy for priests and bans contraception. At a news conference Monday, O’Brien stressed that he merely meant that he would participate in a discussion of those topics if it arose, but that he fully obeyed John Paul’s teachings. "When a decision is made, I ac cept,” he said. O’Brien is the third Scottish cardinal since the Reformation. Ghana is getting its first with Peter Kodwo Appiah Turkson, the archbishop of Cape Coast. And the new Indian cardinal, Ranchi Archbishop Telesphore Placidus Toppo, is the first trib al cardinal. "The Holy Father always looks around to make sure that every part of the human race within the church is recognized in the College of Cardinals,” observed Cardinal Theodore McCarrick, archbishop of Washington, D.C. "And he’s accomplished it really well.” Indeed, under John Paul the college has gotten more interna tional and less Italian, although Europe as a whole still is the largest bloc, followed by the Latin Americans. The Polish-born John Paul broke 455 years of Italian domi nance of the papacy when he was elected pope in 1978. One of the dominant questions now is whether the cardinals will return the papacy to the Italians or look for another nationality, perhaps someone from the devel oping world. "This question of continents isn’t so important,” said Claudio Hummes of Brazil, himself consid ered a papal contender. "The im portant thing in this moment is to ask who could help the church and the world now and in the future.” John Paul named the new group on Sept. 28, acting months before he was expected to amid in creasing concerns about the toll his Parkinson’s disease was tak ing on him. He also announced a 31st car dinal whose name was kept secret, or "in pectore.” That’s a Vatican formula often used when the pope wants to name a cardinal in a coun try where the church is oppressed. The Vatican said John Paul was actually creating 31 cardinals Tuesday, even though only 30 were installed in their new posts. Under church law, an unnamed cardinal enjoys none of the rights or duties of a cardinal until his name is published. If he is under age 80, he wouldn’t be able to vote in a conclave unless John Paul names him before he dies. ^If: F ' ^I PHOTO COURTESY OF KRT CAMPUS On the street that leads to Vatican City, Mother Teresa postcards are displayed for sale on Saturday. John Paul talks about Mother Teresa’s life BY NICOLE WINFIELD THE ASSOCIATED DRESS VATICAN CITY - Pope John Paul II welcomed hundreds of nuns of the Missionaries of Charity order to the Vatican on Monday, telling them at a special audience a day after beatifying Mother Teresa that a life of char ity was the true life of a Christian. John Paul again struggled to get through his remarks, slurring his words and occasionally get ting lost in his text. He did greet dozens of prelates and nuns, and gave a particularly warm wel come to Sister Nirmala, the new superior of the order. “The message of Mother Teresa, now more than ever, ap pears like an invitation to every one,” John Paul said. “Her entire existence reminds us that being Christian means being witness to charity.” On Sunday, the 83-year-old pope presided over Mother Teresa’s beatification ceremony, but was unable to utter a word of his homily — a first for the pope during a major Vatican ceremo ny. Other prelates read the text, as they did Monday during the audience. Mother Teresa, the 1979 Nobel Peace Prize winner, was particu larly beloved by this pope for her life of service to the poor and steadfast adherence to church teaching on opposing contracep tion and abortion. “She always spoke out in de fense of human life, even when her message was unwelcome,” the pope’s text said. “Her daily en counters with death, leprosy, AIDS and every kind of human suffering made her a forceful wit ness to the gospel of life.” In Calcutta, India, her work went on Monday as nuns and vol unteers tended to the dying and destitute at “Nirmal Hriday,” or “Holy Heart” — a center that was opened by Mother Teresa. “The beatification gives us new vigor and zeal because Mother Teresa has been held up as a model of holiness by the Roman Catholic Church,” said Sister Christie of the Missionaries of Charity. “We express all our joy, sor row, gratefulness through prayer and service. So, it’s normal work for us now after a wonderful Sunday,” added Sister Paula Marie. The Roman Catholic Church considers the beatification cere mony the final step before saint hood for the ethnic Albanian nun bom in Skopje, now the capital of Macedonia. It allows her to be called the “Blessed Teresa of Calcutta.” About 300,000 people turned out for Sunday’s ceremony, one of the largest crowds ever at the^f Vatican. As they did on Sunday, the crowd attending Monday’s audi ence applauded whenever John Paul stumbled over his words, en couraging him to continue on. John Paul suffers from Parkinson’s disease, which has made it increasingly difficult for him to speak. He also suffers from hip and knee ailments, which have made it impossible for him to walk or stand. It has been a particularly gru eling few days, and the long cer emonies seem to be taking their toll. John Paul celebrated a Mass marking the 25th anniversary of his pontificate Thursday and on Tuesday is to install 30 new car dinals. . Associated Press writer Nurpur" Banerjee contributed to this story from Calcutta, India. N.C. State student fools papers worldwide with phony research BY MICHELE DECAMP TECHNICIAN (NORTH CAROLINA STATE U.) RALEIGH, N.C. (U-WIRE) - On the surface, it is hard to tell that the story labeled “Study: Fellatio may significantly decrease the risk of breast cancer in women,” isn’t real. The original Web ver sion has the CNN.com banner along the top of the page, the stock CNN medical graphic along the right side of the article and cred its North Carolina State University with the study. But when readers scan the page, names like “Dr. B.J. Sooner” and “Dr. Inserta Shafteer” start to stand out as unusual. However, nothing discredits it more than the fact that Brandon Williamson, a junior at N.C. State in materials science, is the one that wrote it. “I was sitting in the Wolves Den and (the idea for the story) just sparked in my mind as a joke. It didn’t have anything to do with our conversation or anything; it was just something that popped in my head. I ran it by a couple of people, and they thought it would be pretty funny,” Williamson says. He didn’t realize that when he went to the school’s honors lounge and wrote it that his “joke” would become an international news story. “I sent it to 10 people that I thought might find it funny. And a couple of days later I put a thread about it on the Wolf Web. That’s all I did to tell anyone about it. I assumed that it was just going to be one of those things that would be left there and no one would ever see it,” Williamson says. , ,i And for a while, nothing did1 happen. Two weeks went by, and NCSU was preparing for fall break. However, on Oct. 9, Williamson found an unusually large amount of e-mails in his NCSU e-mail ac count about the fellatio story, and he also started to receive some phone calls from the media. _ rm -l _~ t i_u. _ -t Icontraceptive Injectionl Birth control you think about just 4 xayear. medroxyprogesterone acetate injectable suspension DEPO-PROVERA' Contraceptive injection (mcdrofxyprogesterwe acetate injectable suspension. U$P) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive injection is a form of brth confool that s given at an intramuscular njection (a shot) to the txmock or upper arm once every 3 months (13 weeks), lo continue your contraceptive protection, you must return for your next rejection promptly at the end of i months (13 weeks). DEPO-PROVERA contains meifroxyprogesterooe acetate, a chemical sxmfcr to (but not the same as) the natural hormone progesterone, which « produced by your ovaries durna the second half of your menstrual cycle. DEPO PROVERA acts by preventing v°ur egg cefe from ripening. If an egg is not released from foe wanes dura* your memtr»i» cycle, it cannot become fcrtlcwJ by sperm and result m pregnancy. DEPO-PROVERA aho causa changes n the hung of jour uterus that make >t less Weeky for pregpancy to occur. How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive injection depends on following the recommended dosage schedule exactly (see Ttow often do ! get my foot of DEPO-PROVERA Contraceptive tojeeticnr). To make -sure you are not prtgpant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a normal menstrual period: ONLY within the first 5 days after childbirth if not breast-feedtog: and, f exduswefe breast-feeding ONLY at the sixth week after childbirth H » a long-term injectable confoacepbve when adrmmstefed at 3-monfo (l3-week) intervals DEPO-PROVERA Contraceptive fraction is ewer 99% effective, making it one of the most reliable methods of brth control available, mis means that the aver age annual pregnancy rate is less than one for every 100 women who use DEPO-PfO/ERA. The effectiveness of most contraceptive methods depends m part on how refidbly each woman uses the method. The effectiveness of DEPO-PROVERA depends only on the patient rrtummg every 3 monfos Cl 3 weeks) for her next injection 'four heattfveare provider w« help you compare DEPO-PROVERA with other contraceptive methods and £ve you foe information you need n order to decide which contraceptive mefood ft the nght choice for you. The fciowfog table shows foe percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected in women who use each mefood exactly as it shoufo be used) and foe typical rate of pregnancy (which induda women who became pregnant because they forgot to use ther birth ccnfrol or because they (fid not folow foe directions exactly). Percent of Women Experiencing an Accidents! Pregnancy in foe First Year of Continuous Use loom Method Expected Typical .. IjS.I m. ImpiartMNorpaet)0£0?* tenad ner*uuon0204 _Mate geri-tmon 01 __ Ot5 Or?1 canmceptim {pi#) 3 Co*r pined 01 fVofMMMr 0t*f 05 -05-j Ph5f«*aae»-t 2.0 Cott*rT38Q*08 Condor {vxtKx* ymrcdp)2<2 Dsaphragn (wah spemode)418 Cervxai cip6»8 _Wirrdfawal418 Fff-XX _MJ20 Spertrodc alone321 oo^e used beta* <Mdb*nh 4 *8 used alw cNdbrsh 928 f?.«i!sg7Z.7,7lIZZZ.ZliLZZ^^^ SbtMtm: Truse* et a*. Ot**r* Ofoeool 199076*58-567. •from NdrflhW* package «**t Who should not use DEPO-PROVERA Contraceptive Injection? Not al women should use DEPO-PROVERA. too should not use 0F*O-pROV€RA if you h»* ary of the foSovwg conditions: • if ycu think you might be pregnant • if you h»/e any v»gr«l Wecdmg withouta known reason —i-4 • if you have had cancer of the breast • if you have had a stroke • 4 you have or have had Wood dots (phlebitis) h your legs • if you h**e problems wtthyour Iwer or fiver disease • if you arc aikr#: to DEPO-PROVERA (nvxfroxyprogKterone acetate or any of ax other ingredients). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You veil have a physical examination before your doctor prescribes DEPO-PROVERA. It is important to ten your health care provider if you have any of the foBowng • a family history of breast cancer • an aixxxmrf mammogram (breast x-ray). fforocysiic breast disease, breast nodules or lumps, or Weeding from your nipples • kidney disease « rrej^ar or scanty menstrual periods • high Mood pressure • rnwrame headaches • asthma • epilepsy (convulsions or seizures) • diabetes or a family history of diabetes • a history of depression • if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a tong-acting Wi th control method it takes some time after your last injection (or ns effect to wear of. Based on the results from a large study done in the United States, for women who stop using DEPO-PRCVERA in order to become pregftant it is expected that about half of those who become pregnant wS do to m about 10 months after their last injection: about two thuds of these who become pmgjvmt wifi do so m about 12 months about 83% of those who become pregnant w*l do so in about 15 months; and about 93% of those who become pregnant wi do sc in about 18 months after their last injection The length of time you use DTC-fWMM has no eftcxl «t lengit to bcr<^ petspant after wu s?ep usng il What are the risks of using DEPO-PROVERA Contraceptive Injection? J irnsButer Menstwai Shading The side effect reported most frequently by women who use DEPO-PROVERA for wmli-v—AiB « a /Kanor- in ttwt- rvmrm.il menetniii j-vrtf* Phirrw fa-c.t vrvtr r/ itUna DEPO-PRCMRA, you might have one or more of the following changes irregular or 1 unpredictable Weeding or spotting m increase or decrease m menstrual bteedin&or no bleeding at all Unusually heavy or cominuous Weeding, however. is not a usual effect of DtPO PROVERA; i ar>d tf fn happens, you should see yew health-care provider right away With continued use of DEPO-PROVERA, hteecbr«usu,% decreases, and many women stop having periods completely. In clrtcal studies of DEPO*PROVERA 55% of the women studied reported no menstrual Weeding (amenorrhea) after I year of use. and 68% of the women studied reported no menstrual Weedog after 2 years of use. The reason that your periods stop e because DEPO-PROVERA ' causes a resting state in your ovanev When your <y^rm do not release an egg monthly, the regular monthly ayowth of the lining of your uterus does not occur and therefore, the bleeding. ! that comes with your normal menstruation does not take place. When you stop using DEPQ PROVERA your menstrual period w4l usually, in time, return to its normal cycle. 2 Bone Mineral Ctiangts Use of DEPO-PROVERA my be associated with a decrease in the amount of mineral stored n your bones. This could increase your risk of developing bone fractures. The rate of bone mineral loss is greatest m the early years of DEPO-PROVERA use. but after that, it begns to resemfcte the < normal rate of age-related bone mineral loss 3 Can» Studies of women who have used different forms of contraception found that worrier, who used i DEPO-PROVERA for contraception had no ncreased overall risk of developing cancer of the I breast, wary uterus, cervix, or liver. However, women under 25 yean of age whose first exposure to DEPO -PRCMRA was within the previous 4 t.o 5 years may have a slightly increased risk of • developing breast cancer similar to that seen with oral contraceptives. You shoirfd discuss this with your healfrv-careprevider. BecaS*0&O?K%RA * such an effective contraceptive method, the risk of accidental pregywncy for women who get the* ‘hots regularly fevt»> 3 months (13 weeks]) is very tow While there h<*e been reports erf an increased risk of low brth weight and neonatal infant death or other health problems m nfcnts conceived dose to the t*me of injection, such pregnancies are uncommon. If you think you may have become pregnant white using DEPO-PfsUVERA for contraception. see your health-cans provider as soon as possible. 5 Anergic Reactions Some women using DEPO-PROVERA Contraceptive Injection nave reported severe and potentially Sfe-threatening sterge reactions known as anaphylaxis and anaphylactoid reactions. Symptoms axfode the sodden' onset of l*ve* or swelling ,md itching erf tf>e skn breathing difficulties, and a drop m blood pressure. Other R&s Sfew who use hoi'mcoe-based contraceptives may haw? an increased risk of blood dots or treke- Abo, i a contraceptive method fails, there « a polity that the fertifered egg *** be«n 3 develop outside of the uterus (ectopic pregnancy). While these events are rare, you should t3 your health-care provider if you have any of the problems listed n the next setapn. Vhat symptoms mav signal problems while using DEPO-PROVERA Contraceptive Injection? !a8 your heaWnare provider immediately if any of tfwse problems occur following an injection ( DfPO-PROVhPA: sharp chest pain, counting up of blood, or sudden shortness of breath (WfcwRfc a poss&te dot in the lung) sudden severe headache cr vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or teg (indicating a pcss&te stroke) severe pain or svrettng in the calf (indicating a possfote clot in the leg) unuamy heavy vaginal bteedfog severe pan or tenderness in the lower atxkxmvt area persistent pasn. pus. or bleeding at the injection «tc Vhat are the possible side effects of DEPO-PROVERA Contraceptive Injection? W*ghf Gam bu may experience a *tk$n mn white you are usmg DEPO-PROVERA. .About two thirds of ie women who used DEPO-PROVERA n dweaf triah reported a weign gam of aboct 5 pounds wring the first year of use You may continue to gain weight after the first year. Women m one irge study who used D£PO-PROvERA for 2 years gained an average total of 8.1 pounds over lose 2 years, or approwmately 4 pounds per year Women who continued for 4 years gained an rerage total of I l8 pounds over tliose 4 years, or approximately IS pounds per year: Wfcmen ■ho continued for 6 years gamed an average total of 16.5 pounds over those 6 years, or pprrashutdy 2.75 pounds per year 1 Other Side Eftects » a cfrxal study of orer 3,900 women who used OEPOPRQVERA tor up to 7 years, some «xner> reported the fo&ywfog effects that may or may not have been related to their use of JEPO-PROv'ERA: Imephr menstrual Weeding amenorthea, headache, nervousness abdomna* ramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea vagrai fedwrae or imtation, breast swelng and tenderness, bloating svrewng of the hands or feet acfoKhe, depression, insomnia acne, pelvic pam, no hair growth or excessive har loss, rash, hot ashes, and joint pam. Other problems were reported by very lew of the women in tne clncal rats, but some of these could be serious. These indude convulsions, jaundice, umary tract tfechon^, altera* reactions, fainting, parafysH. osteoporosis, lack erf return to ferwjs deep rein -irombo-ss. pulmonary embokis, breast cancer, or cervical cancer. If these or any other problems ccur during your use of DEPO-PROVERA. discuss them with your health-cjrejyowide* ihould anv orecauttons be followed ritirina use of DEPO-PROVERA jontraceptlve injection? Missed f&kxto )oring the tiiw you using OEPO PROV03A for conlraccplioa you m»r skjp a period, or yotr enods may stop complete* If you lure been receiving your DEPO-PROVERA r^ectww every 3 months (13 weeks), then you am probably not pregnant. However. if you thmk l*t you may be pregnant sec your liealth-care provider. 'laboratory Test interactions r you are scheduled for any laboratory tests, te# your health-care provider that you are using ftPO-PROVERA for contraception. Certain Wood tests are affected by hormones such as SPO-PROVERA. ! Drug Interactions lyiadreo (anwcfttaetNmsde) is an antieafxier drug that may significant* decrease the HecUveness ©f DtPO-PROVtRA if the two <frugs ** gh*n during the same time. ! Ni*9rg Mothers 'fthou^i DEPO-PROVERA can be passed to the nursew infant n the breast rwik no harmful fleets nave been kx«id in these children. DEPO-PROVERA does not prevent the breasts from roducra mdc, so it can be used by nursing mothers. However. ;o mtrsmae the amount of JBPO-PROVBRA ihai <s parsed to the Want in die first weeks after Unh. you should wait unti weeks after cbSdbrth before you start iwngOGPO-PROVERA. for contraception tow often do I get my shot of D€PO-PROVERA Contraceptive Injection? he recommended dose of DEPO-PROVERA is 150 mg every 3 roontlhs (13 weeks) Jjven »i a ngfe intramuscular injection r> the buttock or upper arm. To m<ke sum that you are not pregnant t the time of the first injection, it is essential that the injection be giver ONLY duong the first days of a normal menstrual period, if used Mowing the delivery of a chSd, the first injection of JEPO-PROVERA MUST re #v*o within 5 days aft» childbirth if you are not breast-feeefing or i weeks after ch&Jbirth if you are exclusive* breast-feeding. If you wait longer than 3 months 13 weeks) between injections. or longer than 6 weeks after defcvery your health-care provider hould determine that you are not pregnant before giv-ng you your injection of pEPO-PROVERA. be on* CB-7-S Pharmacia sawatfsr &upjohn _5_ vu imuouaj ^ v x wuncu to a guy from Wired News, an on line news site, and he just asked me some questions. There were other people who reprinted it as a real story. I got an e-mail that a Chilean newspaper had reprint ed it, and I got another e-mail with an actual picture of a Croatian newspaper that had printed it up as a real article, say- P , ing that it was from CNN,” Williamson says. “The thing was that what gave the article away originally were the names that I chose. I figured that people who read that would like ‘ha—it’s a joke,’ and the fact that the URL wasn’t a CNN URL. I think what happened was that they got e-mailed a copy of the ar ticle, and if it didn’t have the URL with it or the names were lost in translation, they might not have picked up on it. I would hope that people would ask questions and not just accept what they read,” Williamson says. Once NCSU’s fall break was over, Williamson started to re ceive a different kind of e-mail from David Drooz, the school’s general counsel. “CNN went through Davie r I Drooz. They weren’t happy, and they called it an intellectual prop erties infringement. And the way it works they would pull up liti gation on the school (since the ar- v ticle was on the NCSU Web space). The Associated Press said the same thing,” Williamson says. The article has now been stripped of any connection to real media organizations. Williamson also has been asked by Drooz to remove the NCSU r eferences as well. > i